Results 41 to 50 of about 1,113 (188)

Diagnosis and treatment protocol for COVID‐19 patients (Tentative 10th Version)

Health Care Science, Volume 2, Issue 1, Page 10-24, February 2023., 2023
Abstract To further improve the diagnosis and treatment of COVID‐19, the National Health Commission of People's Republic of China and the National Administration of Traditional Chinese Medicine convened a group of experts to revise the relevant content of the Diagnosis and Treatment Protocol for COVID‐19 Patients (Trial Version 9) and developed the ...
Released by National Health Commission of People's Republic of China & National Administration of Traditional Chinese Medicine on January 5, 2023   +1 more
wiley   +1 more source

TCM2COVID: A resource of anti‐COVID‐19 traditional Chinese medicine with effects and mechanisms

iMeta, Volume 1, Issue 4, December 2022., 2022
TCM2COVID documents over 280 traditional Chinese medicine formulas (including over 300 herbs) with detailed clinical evidence and therapeutic mechanism information; TCM2COVID records over 80 natural products with detailed potential therapeutic mechanisms; TCM2COVID launches a useful web server for querying, analyzing, and visualizing documented ...
Liping Ren, Yi Xu, Lin Ning, Xianrun Pan, Yuchen Li, Qi Zhao, Bo Pang, Jian Huang, Kejun Deng, Yang Zhang   +9 more
wiley   +1 more source

Diagnosis and treatment protocol for COVID‐19 patients (Trial Version 9)

Health Care Science, Volume 1, Issue 1, Page 14-28, August 2022., 2022
Abstract To further improve the diagnosis and treatment of COVID‐19, China National Health Commission and the National Administration of Traditional Chinese Medicine convened a group of experts to revise the relevant content of the Diagnosis and Treatment Protocol for COVID‐19 Patients (Trial Version 8) and developed the Diagnosis and Treatment ...
Released by National Health Commission & National Administration of Traditional Chinese Medicine on March 15, 2022   +1 more
wiley   +1 more source

DataSheet1_Weaker Response to XueBiJing Treatment in Severe Community-Acquired Pneumonia Patients With Higher Body Mass Index or Hyperglycemia: A Post Hoc Analysis of a Randomized Controlled Trial.docx

, 2022
Background: Overweight and hyperglycemia might result in poor prognosis in patients with severe community-acquired pneumonia (SCAP). XueBiJing treatment could significantly improve the outcomes of patients with SCAP.
Tingting Wei (1540081), Dong Yang (141041), Yuanlin Song (131738), Cuicui Chen (7305248), Ke Lang (4162723), Yansha Song (12758045), Xiaocen Wang (4055518)   +6 more
core   +1 more source

Safety of traditional Chinese medicine injection based on spontaneous reporting system from 2014 to 2019 in Hubei Province, China

Scientific Reports, 2021
Traditional Chinese medicine (TCM) injection is widely used in clinical settings, but its adverse drug reactions (ADRs) can be a serious public health concern. The objective is to study the safety of TCM injection and provide suggestions for clinical use.
Rui Huang, Yuanxuan Cai, Linhui Yang, Xiaofang Shangguan, Bishwajit Ghose, Shangfeng Tang   +5 more
doaj   +1 more source

Efficacy of Xuebijing for coagulopathy in patients with sepsis

Saudi Medical Journal, 2015
To provide evidence of the clinical efficacy of Xuebijing (XBJ) on blood coagulation in patients with sepsis.We conducted this meta-analysis in The People's Hospital of Liaoning Province, Shenyang, China between December 2013 and May 2014. We searched a number of databases for relevant randomized controlled trials (RCTs) published before December 2013 ...
Hou, Si-Yuan, Feng, Xing-Huo, Lin, Chang-Liang, Tan, Yong-Feng   +3 more
openaire   +2 more sources

Chinese herbal medicine (“3 medicines and 3 formulations”) for COVID‐19: rapid systematic review and meta‐analysis

Journal of Evaluation in Clinical Practice, Volume 28, Issue 1, Page 13-32, February 2022., 2022
Abstract Background To evaluate the evidence behind claims that Chinese Herbal Medicine, specifically “three medicines and three formulations” (3M3F, comprising Jinhua Qinggan, Lianhua Qingwen, Xuebijing, Qingfei Paidu, Huashi Baidu, and Xuanfei Baidu), is an effective treatment for COVID‐19.
Yangzihan Wang, Trisha Greenhalgh, Jon Wardle, on behalf of the Oxford TCM Rapid Review Team   +3 more
wiley   +1 more source

Pharmacologically significant constituents collectively responsible for anti-sepsis action of XueBiJing, a Chinese herb-based intravenous formulation [PDF]

Acta Pharmacologica Sinica
Mu-Zi Li, Fei-Fei Du, Feng-Qing Wang
exaly   +2 more sources

Effect of a combination of Xuebijing and thymosin α1 on patients with severe pneumonia complicated with sepsis, and its influence on serum inflammatory factors

, 2022
Purpose: To investigate the influence of a combination of Xuebijing and thymosin α1 on acute and septic bronchopneumonia (ASB) patients, and the effect of the treatment on inflammation.
Zhang, Jing, Cao, Jie, Wang, Suhang, Li, Yan   +3 more
core   +1 more source

Retracted: A Case‐Control Study of Continuous Veno‐Venous Hemofiltration Combined with Xuebijing Injection in the Treatment of Severe Sepsis

, 2023
Contrast Media &Molecular Imaging, Volume 2023, Issue 1, 2023.
Contrast Media & Molecular Imaging
wiley   +1 more source